Abstract
Kallikreins are a subgroup of serine proteases with diverse physiological functions. The human kallikrein gene family has now been fully characterized and includes 15 members tandemly located on chromosome 19q13.4 In this review, we discuss the common structural features of kallikreins at the DNA, mRNA and protein levels and summarize their tissue expression and hormonal regulation. Kallikreins are expressed in a wide range of tissues including the salivary gland, endocrine tissues including testis, prostate, breast, endometrium, and the central nervous system. Most, if not all genes are under steroid hormone regulation. The classical kallikreins (KLK1-3) are thought to represent a distinct evolutionary subgroup of kallikreins. The occurrence of several splice variants is a very common phenomenon among kallikreins, and some of the splice variants appear to be tissue-specific and might be related to certain pathological conditions. We also provide a summary of predicted and experimentally confirmed promoter elements of kallikrein genes and describe repeat elements and polymorphisms within this genomic region.
Keywords: kallikreins, klk1, klk1-3, klk1-15
Current Genomics
Title: Human Kallikreins: Common Structural Features, Sequence Analysis and Evolution
Volume: 4 Issue: 2
Author(s): George M. Yousef and Eleftherios P. Diamandis
Affiliation:
Keywords: kallikreins, klk1, klk1-3, klk1-15
Abstract: Kallikreins are a subgroup of serine proteases with diverse physiological functions. The human kallikrein gene family has now been fully characterized and includes 15 members tandemly located on chromosome 19q13.4 In this review, we discuss the common structural features of kallikreins at the DNA, mRNA and protein levels and summarize their tissue expression and hormonal regulation. Kallikreins are expressed in a wide range of tissues including the salivary gland, endocrine tissues including testis, prostate, breast, endometrium, and the central nervous system. Most, if not all genes are under steroid hormone regulation. The classical kallikreins (KLK1-3) are thought to represent a distinct evolutionary subgroup of kallikreins. The occurrence of several splice variants is a very common phenomenon among kallikreins, and some of the splice variants appear to be tissue-specific and might be related to certain pathological conditions. We also provide a summary of predicted and experimentally confirmed promoter elements of kallikrein genes and describe repeat elements and polymorphisms within this genomic region.
Export Options
About this article
Cite this article as:
Yousef M. George and Diamandis P. Eleftherios, Human Kallikreins: Common Structural Features, Sequence Analysis and Evolution, Current Genomics 2003; 4 (2) . https://dx.doi.org/10.2174/1389202033350074
DOI https://dx.doi.org/10.2174/1389202033350074 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Plants vs. Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability
Anti-Cancer Agents in Medicinal Chemistry Applications of HPLC-MALDI-TOF MS/MS Phosphoproteomic Analysis in Oncological Clinical Diagnostics
Current Proteomics Survey of Functional Activities of Alpha-fetoprotein Derived Growth Inhibitory Peptides: Review and Prospects
Current Protein & Peptide Science Targeting the Type I Insulin-Like Growth Factor System for Breast Cancer Therapy
Current Drug Targets Signal Transduction Pathways of Inflammatory Gene Expressions and Therapeutic Implications
Current Pharmaceutical Design Melatonin and Respiratory Diseases: A Review
Current Topics in Medicinal Chemistry Variances in the Level of COX-2 and iNOS in Different Grades of Endometrial Cancer
Current Pharmaceutical Biotechnology Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis
Current Pharmaceutical Design Emerging Role of Apelin as a Therapeutic Target in Cancer: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery Endothelial Progenitor Cells: A Vascular Perspective for Inflammatory Rheumatic Disorders
Current Rheumatology Reviews Synthesis and Biological Activity of 3-N-Substituted Estrogen Derivatives as Breast Cancer Agents
Mini-Reviews in Medicinal Chemistry Therapeutic Perspectives of Inhibitors of Endocannabinoid Degradation
Current Drug Targets - CNS & Neurological Disorders Role of Unani Medicines in Cancer Control and Management
Current Drug Therapy Noncovalent Binding to DNA: Still a Target in Developing Anticancer Agents
Current Medicinal Chemistry Recent Clinical Aspects of Hyperprolactinemia Induced by Antipsychotics
Reviews on Recent Clinical Trials Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer
Current Neurovascular Research Oncostatin M: Potential Implications for Malignancy and Metabolism
Current Pharmaceutical Design Diabetes Mellitus: Channeling Care through Cellular Discovery
Current Neurovascular Research HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Current Pharmaceutical Biotechnology